Working Together to Find the New Standard of Care

Andrey Antov, PhD, MBA

Video Categories: 2018 AONN Midyear and Video Library

Dr Andrey Antov values the benefits of working within an interdisciplinary team to advance cancer care and help patients.

July 13, 2021

Making a Difference with Early Identification and Treatment of Patients with NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, explain the benefits of testing for TRK fusion–positive tumors early for improved clinical outcomes.

August 29, 2018

Accurate and Reproducible Measurement of PD-1/PD-L1

Drs. Geoff Oxnard and Lauren Ritterhouse discuss PD-1/PD-L1 as a routine biomarker test run on all lung cancer biopsy specimens, as well as on other selected cancer types, and how qualitative and quantitative results are typically reported.